Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Cited by (1,002)

Items 101–200 of 1,002

1. MAIT cell activation and dynamics associated with COVID-19 disease severity
   Tiphaine Parrot, Jean‐Baptiste Gorin, Andrea Ponzetta, Kimia T. Maleki, Tobias Kammann, Johanna Emgård, André Perez‐Potti, Takuya Sekine, Olga Rivera‐Ballesteros, the Karolinska COVID-19 Study Group et al. · 2020 · Science Immunology
2. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
   Aaron J. Wilk, Madeline J. Lee, Bei Wei, Benjamin E. Parks, Ruoxi Pi, Giovanny J. Martínez-Colón, Thanmayi Ranganath, Nancy Q. Zhao, Shalina Taylor, Winston R. Becker et al. · 2021 · The Journal of Experimental Medicine
3. On the whereabouts of SARS-CoV-2 in the human body: A systematic review
   Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove · 2020 · PLoS Pathogens
4. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
   Can Liu, Andrew J. Martins, William W. Lau, Nicholas Rachmaninoff, Jinguo Chen, Luisa Imberti, Darius Mostaghimi, Danielle L. Fink, Peter D. Burbelo, Kerry Dobbs et al. · 2021 · Cell
5. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection
   Michaela Restivo Anderson, Joshua D. Geleris, David R. Anderson, Jason E Zucker, Yael R. Nobel, Daniel E. Freedberg, Jennifer L. Small-Saunders, Kartik N. Rajagopalan, Richard A. Greendyk, Sae‐Rom Chae et al. · 2020 · Annals of Internal Medicine
6. Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
   Theoharis Constantin Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, Antonios M. Politis · 2021 · BioFactors
7. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc
   Giuseppe Magro · 2020 · Cytokine X
8. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
   Jinlan Zhang, Yuhuan Li, Lulu Wang, Hongqi Liu, Shuaiyao Lu, Yong Liu, Ke Li, Bin Liu, Suyun Li, Fengmin Shao et al. · 2021 · Signal Transduction and Targeted Therapy
9. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
   Rafael B. Polidoro, Robert S. Hagan, Roberta Ribeiro De Santis Santiago, Nathan W. Schmidt · 2020 · Frontiers in Immunology
10. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2
    Chia-Ming Su, Leyi Wang, Dongwan Yoo · 2021 · Scientific Reports
11. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death
    Felicia Ceban, Danica Nogo, Isidro P. Carvalho, Yena L. Lee, Flora Nasri, Jiaqi Xiong, Leanna M.W. Lui, Mehala Subramaniapillai, Hartej Gill, Rene N. Liu et al. · 2021 · JAMA Psychiatry
12. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case–cohort study from the multicentric OUTCOMEREA network
    Niccolò Buetti, Stéphane Ruckly, Étienne de Montmollin, Jean Reignier, Nicolas Terzi, Yves Cohen, Shidasp Siami, Claire Dupuis, JF Timsit · 2021 · Intensive Care Medicine
13. Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection
    Seyedeh Maryam Zekavat, Shu‐Hong Lin, Alexander G. Bick, Aoxing Liu, Kaavya Paruchuri, Chen Wang, Md Mesbah Uddin, Yixuan Ye, Zhaolong Yu, Xiaoxi Liu et al. · 2021 · Nature Medicine
14. A single-cell transcriptomic landscape of the lungs of patients with COVID-19
    Si Wang, Xiaohong Yao, Shuai Ma, Yi‐Fang Ping, Yanling Fan, Shuhui Sun, Zhicheng He, Yu Shi, Liang Sun, Shiqi Xiao et al. · 2021 · Nature Cell Biology
15. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
    David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, Michael Laffan, Maximilian Ackermann, Julie Helms, Danny David Jonigk, Richard Chocron, Gerald B. Pier, Nicolas Gendron et al. · 2021 · Angiogenesis
16. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
    Alon, Ronen, Sportiello, Mike, Kozlovski, Stav, Kumar, Ashwin, Reilly, Emma C., Zarbock, Alexander, Garbi, Natalio, Topham, David J. · 2021 · Nature Reviews Immunology
17. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome
    Sophie Hüe, Asma Beldi‐Ferchiou, Inès Bendib, Mathieu Surénaud, Slim Fourati, Thomas Frapard, Simon Rivoal, Keyvan Razazi, Guillaume Carteaux, Marie‐Hélène Delfau‐Larue et al. · 2020 · American Journal of Respiratory and Critical Care Medicine
18. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
    Rita Carsetti, Salvatore Zaffina, Eva Piano Mortari, Sara Terreri, Francesco Corrente, Claudia Capponi, Patrizia Palomba, Mattia Mirabella, Simona Cascioli, Paolo Palange et al. · 2020 · Frontiers in Immunology
19. Activation or exhaustion of CD8+ T cells in patients with COVID-19
    Min‐Seok Rha, Eui‐Cheol Shin · 2021 · Cellular and Molecular Immunology
20. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis
    Asma Fatima Boumaza, Laëtitia Gay, Soraya Mezouar, Eloïne Bestion, Aïssatou Bailo Diallo, Moïse Michel, Benoît Desnues, Didier Raoult, Bernard La Scola, Philippe Halfon et al. · 2021 · The Journal of Infectious Diseases
21. Pneumothorax in COVID-19 disease- incidence and clinical characteristics
    Massa Zantah, E. Dominguez Castillo, Ryan Townsend, Fusun Dikengil, Gerard J. Criner · 2020 · Respiratory Research
22. What causes hidradenitis suppurativa ?—15 years after
    Christos C. Zouboulis, Farida Benhadou, Angel S. Byrd, Nisha Suyien Chandran, Evangelos J. Giamarellos‐Bourboulis, Gabriella Fabbrocini, John W. Frew, Hideki Fujita, Marcos Antonio González-López, Philippe Guillem et al. · 2020 · Experimental Dermatology
23. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
    Lok-Yin Roy Wong, Stanley M. Perlman · 2021 · Nature reviews. Immunology
24. The humoral response and antibodies against SARS-CoV-2 infection
    Hai Qi, Bo Liu, Xin-Quan Wang, Lin-Qi Zhang · 2022 · Nature Immunology
25. T Cells: Warriors of SARS-CoV-2 Infection
    Paola de Candia, Francesco Prattichizzo, S. Garavelli, Giuseppe Matarese · 2020 · Trends in Immunology
26. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
    Jesper Damsgaard Gunst, Nina Breinholt Stærke, Marie Høst Pahus, Lena Hagelskjær Kristensen, Jacob Bodilsen, Nicolai Lohse, Lars Dalgaard, Dorthe Brønnum, Ole Fröbert, Bo Langhoff Hønge et al. · 2021 · EClinicalMedicine
27. Innate immunological pathways in COVID-19 pathogenesis
    Søren R. Paludan, Trine Hyrup Mogensen · 2022 · Science Immunology
28. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
    Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Maria Notomi Sato · 2020 · Frontiers in Immunology
29. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19
    Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman · 2020 · Viruses
30. An open label trial of anakinra to prevent respiratory failure in COVID-19
    Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George Ν. Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, Eleni Karakike, Maria Saridaki, Georgia Loli, Aggelos Stefos et al. · 2021 · eLife
31. COVID-19 and mucormycosis superinfection: the perfect storm
    Jaffar A. Al‐Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani A. Temsah, Mazin Adnan Barry, Abbas Saleh Al Mutair, Ali Ahmed Rabaan, Awad Al‐Omari, Raghavendra Tirupathi, Manaf AlQahtani et al. · 2021 · Infection
32. Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis*
    Eleni Karakike, Evangelos J. Giamarellos‐Bourboulis, Miltiades Kyprianou, Carolin Fleischmann-Struzek, Mathias Wilhelm Pletz, Mihai Gheorghe Netea, Konrad Reinhart, Evdoxia Kyriazopoulou · 2021 · Critical Care Medicine
33. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19
    Avraham Unterman, Tomokazu S. Sumida, Nima Nouri, Xiting Yan, Amy Zhao, Victor Gasque, Jonas C. Schupp, Hiromitsu Asashima, Yunqing Liu, Carlos Cosme et al. · 2022 · Nature Communications
34. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
    Guido Moll, Norman Michael Drzeniek, Julian Kamhieh‐Milz, Sven Geißler, Hans‐Dieter Volk, Petra Reinke · 2020 · Frontiers in Immunology
35. Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
    Samuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, Paola Gruarin, Valeria Bevilacqua, Anna Rita Putignano, Andrea Gobbini, Eugenia Galeota, Cristina Manara, Mauro Bombaci et al. · 2021 · Science Immunology
36. Is pregnancy a risk factor of COVID-19?
    Wendy Nokhwezi Phoswa, Olive Pearl Khaliq · 2020 · European Journal of Obstetrics & Gynecology and Reproductive Biology
37. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19
    Wenjing Ye, Guoxi Chen, Xiaopan Li, Xing Lan, Chen Ji, Min Hou, Di Zhang, Guangwang Zeng, Yaling Wang, Cheng Xu et al. · 2020 · Respiratory Research
38. Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
    Milena Sokołowska, Zuzanna Małgorzata Łukasik, Ioana Octavia Agache, Cezmi A. Akdiş, Deniz Akdiş, Mübeccel Akdiş, Weronika Barcik, Helen Annaruth Brough, Thomas Eiwegger, Andrzej Eljaszewicz et al. · 2020 · Allergy
39. Peripheral and lung resident memory T cell responses against SARS-CoV-2
    Judith Grau-Expósito, Nerea Sánchez-Gaona, Núria Massana, Marina Suppi, Antonio Astorga-Gamaza, David Perea, Joel Rosado, Anna Falcó-Roget, Cristina Kirkegaard-Biosca, Ariadna Torrella et al. · 2021 · Nature Communications
40. Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
    Francesco Salton, Paola Confalonieri, Gianfranco Umberto Meduri, Pierachille Santus, Sergio Alfonso Harari, Raffaele Scala, Simone Lanini, Valentina Vertui, Tiberio Oggionni, Antonella Caminati et al. · 2020 · Open Forum Infectious Diseases
41. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
    Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, Christine Lacabaratz, Matthieu Perreau, Emile Foucat, Marie Déchenaud et al. · 2021 · iScience
42. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
    F. J. Salguero, A. White, G. Slack, S. Fotheringham, Kevin R. Bewley, K. Gooch, S. Longet, H. Humphries, R. Watson, Laura Hunter et al. · 2021 · Nature Communications
43. COVID-19: Complement, Coagulation, and Collateral Damage
    Martin W. Lo, Claudia Kemper, Trent M. Woodruff · 2020 · The Journal of Immunology
44. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
    Lu Qiao, Jia Liu, Shuai Zhao, María Florencia Gómez Castro, Maudry Laurent-Rolle, Jianbo Dong, Xiaojuan Ran, Payal Damani‐Yokota, Hongzhen Tang, Triantafyllia R. Karakousi et al. · 2021 · Immunity
45. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity
    Mélissa Saichi, Maha Zohra Ladjemi, Sarantis Korniotis, C. Rousseau, Zakaria Ait Hamou, Lucile Massenet-Regad, Elise Amblard, Floriane Noël, Yannick Marie, Delphine Bouteiller et al. · 2021 · Nature Cell Biology
46. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans
    Zhipeng Yan, Ming Yang, Ching‐Lung Lai · 2021 · Biomedicines
47. Genetic gateways to COVID‐19 infection: Implications for risk, severity, and outcomes
    Monojit Debnath, Moinak Banerjee, Michael Berk · 2020 · The FASEB Journal
48. Pathogenesis of Respiratory Viral and Fungal Coinfections
    Fabián Salazar, Elaine Bignell, Gordon D. Brown, Peter C. Cook, Adilia Warris · 2021 · Clinical Microbiology Reviews
49. Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study‘
    Maria De Santis, Antonio Voza, Victor Savevski, Salvatore Badalamenti, Maurizio Cecconi, Alberto Mantovani, Carlo Francesco Selmi · 2021 · Annals of the Rheumatic Diseases
50. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
    Marisa Market, Leonard Angka, Andre B. Martel, Donald J. Bastin, Oladunni Olanubi, Gayashan Tennakoon, Dominique M. Boucher, Juliana Ng, Michele Ardolino, Rebecca C. Auer · 2020 · Frontiers in Immunology
51. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
    Theoharis Constantin Theoharides · 2022 · Molecular Neurobiology
52. Pulmonary fibrosis in the aftermath of the Covid-19 era (Review)
    Eirini Vasarmidi, Eliza Tsitoura, Demetrios A. Spandidos, Νikolaos Tzanakis, Katerina M. Antoniou · 2020 · Experimental and Therapeutic Medicine
53. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
    Magali Noval Rivas, Joseph E. Ebinger, Min Wu, Nancy Sun, Jonathan G. Braun, Kimia Sobhani, Jennifer E. Van Eyk, Susan C. Cheng, Moshe Arditi · 2020 · Journal of Clinical Investigation
54. Natural history of COVID-19 and therapeutic options
    Philippe Gautret, Matthieu Million, Pierre‐André Jarrot, Laurence Camoin‐Jau, Philippe Colson, Florence Fenollar, Marc Léone, Bernard La Scola, Christian Albert Devaux, Jean Yves Gaubert et al. · 2020 · Expert Review of Clinical Immunology
55. Monocytes and macrophages in COVID-19: Friends and foes
    Sepideh Meidaninikjeh, Nasim Sabouni, Hadi Zare Marzouni, Sajad Bengar, Ahmad Khalili, Reza Jafari · 2021 · Life Sciences
56. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
    Marianna Caterino, Monica Gelzo, Stefano Sol, Roberta Fedele, Anna Annunziata, Cecilia Calabrese, Giuseppe Fiorentino, Maurizio D’Abbraccio, Chiara Dell’Isola, Francesco Maria Fusco et al. · 2021 · Scientific Reports
57. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging
    Sofie Hedlund Møller, Pei‐Chun Hsueh, Yi-Ru Yu, Lianjun Zhang, Ping‐Chih Ho · 2022 · Cell Metabolism
58. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis
    Yanan Chu, Jinxiu Yang, Jiaran Shi, Pingping Zhang, Xingxiang Wang · 2020 · European journal of medical research
59. Covid-19: Perspectives on Innate Immune Evasion
    Nima Taefehshokr, Sina Taefehshokr, Nima Hemmat, Bryan Heit · 2020 · Frontiers in Immunology
60. Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
    Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, Pejman Mokhtari, Maryam Nemati · 2020 · Scandinavian Journal of Immunology
61. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients
    Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren Friedman, Joseph Alexander Palatinus, Nirmala S. Surapaneni, Yuri P. Matusov, Giuliana Cerro Chiang, Alexander G. Kassar et al. · 2020 · Cell Reports
62. GM-CSF: A Promising Target in Inflammation and Autoimmunity
    Ming-Chin Lee, Adrian A. Achuthan, John A. Hamilton · 2020 · ImmunoTargets and Therapy
63. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
    Jozefien Declercq, Karel F. A. Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cédric Bosteels, Simon Jan Tavernier, Stefanie L. De Buyser, Roos Colman, Maya Hites, Gil Verschelden et al. · 2021 · The Lancet Respiratory Medicine
64. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure
    Wesley Tyler Abplanalp, Silvia Mas‐Peiró, Sebastian Cremer, David John, Stefanie Dimmeler, Andreas Michael Zeiher · 2020 · JAMA Cardiology
65. A distinct innate immune signature marks progression from mild to severe COVID-19
    Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, Sarah Adamo, Miro E. Raeber, Natalie de Souza, Sujana Sivapatham, Andrea Jacobs, Esther Bächli, Alain Rudiger et al. · 2020 · Cell Reports Medicine
66. The RNA sensor MDA5 detects SARS-CoV-2 infection
    Natália G. Sampaio, Lise Chauveau, Jonny Hertzog, Anne Bridgeman, Gerissa Fowler, Jurgen P. Moonen, Maeva Dupont, Rebecca A Russell, Marko Noerenberg, Jan Rehwinkel · 2021 · Scientific Reports
67. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
    Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, Chih-Hung Ye, SuiYun Hu, Patrick Chun Theng Chong, Kah Yi Yap, Jamie Yu Chieh Lee, Weichen Lin, Shu‐Han Yu · 2022 · Frontiers in Immunology
68. How to interpret and use COVID-19 serology and immunology tests
    David S. Y. Ong, Paraskevi C. Fragkou, Valentijn A. Schweitzer, Roy F. Chemaly, Charalampos D. Moschopoulos, Chrysanthi L. Skevaki · 2021 · Clinical Microbiology and Infection
69. Persistent cellular immunity to SARS-CoV-2 infection
    Breton, Gaëlle, Mendoza, Pilar, Hägglöf, Thomas, Oliveira, Thiago Y., Schaefer-Babajew, Dennis, Gaebler, Christian, Turroja, Martina, Hurley, Arlene, Caskey, Marina, Nussenzweig, Michel C. · 2021 · Journal of Experimental Medicine
70. Sex‐based differences in severity and mortality in COVID‐19
    Mustafa Mohamed Alwani, Aksam A Yassin, Raed M. Al‐Zoubi, Omar M. Aboumarzouk, Joanne E. Nettleship, Daniel Marcus Kelly, Ahmad Rajeh Al-Qudimat, Ridwan Shabsigh · 2021 · Reviews in Medical Virology
71. Targeting TNF-α for COVID-19: Recent Advanced and Controversies
    Yi Guo, Ke Hu, Yuxuan Li, Chanjun Lu, Ken Ling, Chuanqi Cai, Weici Wang, Dawei Ye · 2022 · Frontiers in Public Health
72. Severe COVID-19 and aging: are monocytes the key?
    Brandt D. Pence · 2020 · GeroScience
73. Role of computed tomography in COVID-19
    Gianluca Pontone, Stefano Scafuri, Maria Elisabetta Mancini, Cecilia Agalbato, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Daniele Andreini, Saima Mushtaq et al. · 2020 · Journal of cardiovascular computed tomography
74. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
    Aristo Vojdani, Elroy Vojdani, Evan Saidara, Michael H. J. Maes · 2023 · Viruses
75. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism
    Hélène Blasco, C. Bessy, Laurent Plantier, Antoine Lefèvre, Éric Piver, Louis Bernard, Julien Marlet, Karl Stéfic, Isabelle Benz‐de Bretagne, P. Cannet et al. · 2020 · Scientific Reports
76. Efficacy and tolerability of bevacizumab in patients with severe Covid-19
    Jiaojiao Pang, Feng Xu, Gianmarco Aondio, Yu Li, Alberto Fumagalli, Ming Lü, Giuseppe Valmadre, Jie Wei, Yuan Bian, Margherita Canesi et al. · 2021 · Nature Communications
77. Effect of heart failure on the outcome of COVID-19 — A meta analysis and systematic review
    Emir Yonas, Idrus Alwi, Raymond Pranata, Ian Huang, Michael Anthonius Lim, Eddy Jose Gutierrez, Muhammad Yamin, Bambang Budi Siswanto, Salim S. Virani · 2020 · The American Journal of Emergency Medicine
78. Lymphopenia Caused by Virus Infections and the Mechanisms Beyond
    Zijing Guo, Zhidong Zhang, Meera Prajapati, Yanmin Li · 2021 · Viruses
79. COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
    Giuseppe Magro · 2020 · Virus Research
80. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related Disease
    Mayte Suárez‐Fariñas, Minami A. Tokuyama, Gabrielle Wei, Ruiqi Huang, Alexandra E. Livanos, Divya Jha, Anaïs Levescot, Haritz Irizar, Roman Kosoy, Sascha Cording et al. · 2020 · Gastroenterology
81. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness
    Zuzana Paračková, Irena Zentsová, Markéta Bloomfield, Petra Vrabcová, Jitka Smetanová, Adam Klocperk, Grigorij Mesežnikov, Luis Fernando Casas Méndez, Tomáš Vymazal, Anna Šedivá · 2020 · Cells
82. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
    Egle Kvedaraite, Laura Hertwig, Indranil Sinha, Andrea Ponzetta, Ida Hed Myrberg, Magda Lourda, Majda Dzidic, Mira Akber, Jonas Klingström, Elin Folkesson et al. · 2021 · Proceedings of the National Academy of Sciences
83. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
    Upendra Katneni, Aikaterini Alexaki, Ryan Hunt, Tal Schiller, Michael N. DiCuccio, Paul W. Buehler, Juan C. Ibla, Chava Kimchi‐Sarfaty · 2020 · Thrombosis and Haemostasis
84. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Jean‐Michel Sallenave, Loïc Guillot · 2020 · Frontiers in Immunology
85. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
    Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Megan Gallogly, Marcos J. G. De Lima, Muhammad Rizwan Sohail · 2020 · Virology Journal
86. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
    the RCI-COVID-19 Study Group, Kooistra, Emma J., Waalders, Nicole J. B., Grondman, Inge, Janssen, Nico A. F., de Nooijer, Aline H., Netea, Mihai G., van de Veerdonk, Frank L., Ewalds, Esther, van der Hoeven, Johannes G. et al. · 2020 · Critical Care
87. Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis
    Miloš Jeseňák, Miroslava Brndiarová, Ingrid Urbančíková, Zuzana Rennerová, Jarmila Vojtková, Anna Bobčáková, Róbert Ostró, Peter Bánovčin · 2020 · Frontiers in Cellular and Infection Microbiology
88. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
    Hossein Khorramdelazad, Mohammad Hossein Kazemi, Alireza Najafi, Maryam Keykhaee, Reza Zolfaghari Emameh, Reza Falak · 2020 · Microbial Pathogenesis
89. COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
    Carmen Andrea Pfortmueller, Thibaud Spinetti, Richard D. Urman, Markus Martin Luedi, Joerg C. Schefold · 2020 · Best practice & research. Clinical anaesthesiology
90. The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors
    Anja Hafner Pišlar, Ana Mitrović, Jerica Sabotič, Urša Pečar Fonović, Milica Perišić Nanut, Tanja Jakoš, Emanuela Senjor, Janko Kos · 2020 · PLoS Pathogens
91. The Role of Ferritin in Health and Disease: Recent Advances and Understandings
    Nikhil Kumar Kotla, Priyata Dutta, Sanjana Parimi, Nupur Kanti Das · 2022 · Metabolites
92. COVID-19 convalescent plasma composition and immunological effects in severe patients
    Yeny Acosta‐Ampudia, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Juan Esteban Gallo, Juan Carlos Salazar-Uribe, María José Santander, Mónica P. Cala, Wildeman Zapata, Maria Isabel Zapata-Cardona et al. · 2021 · Journal of Autoimmunity
93. Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
    Xiaorong Peng, Jing Ouyang, Stéphane Isnard, John Chia-Yang Lin, Brandon Fombuena, Biao Zhu, Jean‐Pierre Routy · 2020 · Frontiers in Immunology
94. The role of IL-6 and IL-6 blockade in COVID-19
    Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, Ettore Porreca, Antonella Cappelli, Antonio Abbate, Francesco Dentali, Aldo Bonaventura · 2021 · Expert Review of Clinical Immunology
95. Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
    Gangaev, Anastasia, Ketelaars, Steven L. C., Isaeva, Olga I., Patiwael, Sanne, Dopler, Anna, Hoefakker, Kelly, De Biasi, Sara, Gibellini, Lara, Mussini, Cristina, Guaraldi, Giovanni et al. · 2021 · Nature Communications
96. The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study
    Valentina Baccolini, Giuseppe Migliara, Claudia Isonne, Barbara Dorelli, L. C. Barone, Dara Giannini, Daniela Marotta, Mattia Marte, Elena Mazzalai, Francesco Alessandri et al. · 2021 · Antimicrobial Resistance and Infection Control
97. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
    Raphaël Carapito, Richard Y. Li, Julie Helms, Christine Carapito, Sharvari Gujja, Véronique Rolli, Raony Guimaraes, Jose Malagon-Lopez, Perrine Spinnhirny, Alexandre Lederle et al. · 2021 · Science Translational Medicine
98. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
    Rainer W. J. Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, Raphael Escaig, Afra Anjum, Marie‐Louise Hoffknecht, Christoph Gold et al. · 2021 · JCI Insight
99. Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy
    Florentia Dimitriou, Sabrina A. Hogan, Alexander Maxwell Menzies, Reinhard Dummer, Georgina Venetia Long · 2021 · European Journal of Cancer
100. Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections
     Sadeep Medhasi, Narisara Chantratita · 2022 · Journal of Immunology Research